ETFs Holding AMPE »    AMPE Historical Stock Prices »
AMPE News Video: Mon, Aug 25, 2014, 1:12 PM — Monday Sector Leaders: Biotechnology, Drugs

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Ampio Pharmaceuticals is a biopharmaceutical company focused primarily on the development of therapies to treat inflammatory conditions. Co. is primarily developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level; activating specific phosphatase or depleting available phosphate needed for the inflammation process; and decreasing vascular permeability. Co.'s product pipeline includes Ampion, which Co. is developing as an intra-articular injection to treat pain due to osteoarthritis of the knee; and Optina, which Co. is developing to treat diabetic macular edema. Self directed investors in Ampio Pharmaceuticals Inc will be interested in keeping up with all Ampio Pharmaceuticals Inc news they can find, both AMPE news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on AMPE. At RediNews, we simplify this task by presenting both AMPE news releases originating from Ampio Pharmaceuticals Inc itself, and AMPE news from a variety of media outlets. Visitors can browse this news online and through our AMPE RSS news feed.


AMPE News — Articles, Videos, & Press Releases

Noteworthy Wednesday Option Activity: ORA, WMT, AMPE
Wednesday, November 7, 2018, 3:26 PM — Stock Options Channel
First Week of AMPE January 2021 Options Trading
Tuesday, September 18, 2018, 10:54 AM — Stock Options Channel
Ampio Pharmaceuticals Stock Sees Short Interest Decrease By 14%
Monday, August 27, 2018, 11:56 AM — Market News Video
Notable Monday Option Activity: AMPE, CBOE, EGN
Monday, August 6, 2018, 3:17 PM — Stock Options Channel
Noteworthy Friday Option Activity: CIT, AMPE, AN
Friday, July 20, 2018, 3:38 PM — Stock Options Channel
Commit To Purchase Ampio Pharmaceuticals At $2, Earn 60.2% Annualized Using Options
Thursday, July 5, 2018, 11:49 AM — Stock Options Channel
AMPE is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:


RediNews invites those seeking web page financial content for any internet portal, especially any vertical portal specializing in the markets where there is a web page for business, web page for markets, web page finance, etc., to integrate our free web site content, our RSS news feeds. These RSS feeds are found throughout our website wherever news and custom stock content is found, by clicking the RSS icon for any news page (which will look like this): . This dynamic financial content is ideal for sites that already feature stock data content such as historical stock price information whether in the form of a historical stock price table or a web page chart image, to supplement the other custom stock market content displayed.

AMPE News | | Copyright © 2013 - 2019, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.